Literature DB >> 12811605

The patient with medication overuse: clinical management problems.

F Frediani1, A P Cannatà, A Magnoni, C Peccarisi, G Bussone.   

Abstract

Patients with chronic headache arise many problems in clinical management, often strictly related to medication overuse. IHS classification did not clear the different clinical presentation and a chapter dedicated to this problem is lacking. This condition is very frequently associated with psychiatric illness, so that the clinical features become more complex over the years. Most of patients share a past clinical condition of episodic migraine; this aspect is very important facing the therapeutical phase, because after discontinuing medication overuse, if present, the treatment must be direct toward this disease. To treat a patient with analgesic, or ergotamine, or triptan abuse, require much caution because stopping the drug may arise new problems, such as different headache, abstinence syndrome, epileptic seizures etc. We review the different possibility that we have to manage the overuser patient.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12811605     DOI: 10.1007/s100720300054

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  4 in total

1.  Ergotism with ischemia in all four extremities: a case report.

Authors:  Seok-Young Jeong; Eui-Seong Lim; Byoung-Soo Shin; Man-Wook Seo; Young-Hyun Kim; Hyo-Sung Kwak; Gyung-Ho Chung; Seul-Ki Jeong
Journal:  J Clin Neurol       Date:  2006-12-20       Impact factor: 3.077

2.  Refill non-adherence to repeat prescriptions leads to treatment gaps or to high extra costs.

Authors:  Kristin Krigsman; Arne Melander; Anders Carlsten; Anders Ekedahl; J Lars Nilsson
Journal:  Pharm World Sci       Date:  2007-02

Review 3.  Medication overuse headache: awareness, detection and treatment.

Authors:  Alan M Rapoport
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

4.  Medicine possession ratio as proxy for adherence to antiepileptic drugs: prevalence, associations, and cost implications.

Authors:  Karen Jacobs; Marlene Julyan; Martie S Lubbe; Johanita R Burger; Marike Cockeran
Journal:  Patient Prefer Adherence       Date:  2016-04-12       Impact factor: 2.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.